rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
1	Hypertension	C0020538	2	1647	0.0	1.24069478908e-06	BCL2,TUBB1
3	Myocardial Infarction	C0027051	2	1019	0.0	3.72208436725e-06	BCL2,TUBB1
4	Stroke	C0038454	2	1229	0.0	4.96277915633e-06	BCL2,TUBB1
7	Abnormality of blood and blood-forming tissues	C0241657	2	1335	0.0	8.68486352357e-06	BCL2,TUBB1
11	Acute Coronary Syndrome	C0948089	2	320	0.0	1.36476426799e-05	BCL2,TUBB1
16	Cerebral Hemorrhage	C2937358	2	246	0.0	1.98511166253e-05	BCL2,TUBB1
146	Hypercapnia	C0020440	1	25	1.0329579172019265e-06	0.000181141439206	BCL2
147	Oculopharyngeal muscular dystrophy	C0270952	1	25	1.0329579172019265e-06	0.000182382133995	BCL2
148	Cutaneous lymphoma	C1276146	1	25	1.0329579172019265e-06	0.000183622828784	BCL2
149	Plasmablastic lymphoma	C0079746	1	26	1.1190828040907874e-06	0.000184863523573	BCL2
150	Lymphoid hyperplasia	C0333997	1	26	1.1190828040907874e-06	0.000186104218362	BCL2
151	Malignant neoplasm of adrenal cortex	C0346402	1	26	1.1190828040907874e-06	0.000187344913151	BCL2
152	Oropharynx (excludes nasopharynx)	C0521367	1	26	1.1190828040907874e-06	0.00018858560794	BCL2
153	Cervical dysplasia	C0007868	1	27	1.2086057297189257e-06	0.00018982630273	BCL2
154	Cryoglobulinemia	C0010403	1	27	1.2086057297189257e-06	0.000191066997519	BCL2
155	Seborrheic keratosis	C0022603	1	27	1.2086057297189257e-06	0.000192307692308	BCL2
156	Gallbladder adenocarcinoma	C0279651	1	27	1.2086057297189257e-06	0.000193548387097	BCL2
157	Fowlpox	C0016629	1	28	1.3015258377713224e-06	0.000194789081886	BCL2
158	Chromosomal translocation	C0040715	1	29	1.3979886140935704e-06	0.000196029776675	BCL2
159	Carcinoma, Signet Ring Cell	C0206696	1	29	1.3979886140935704e-06	0.000197270471464	BCL2
160	Squamous Cell Neoplasms	C0206720	1	29	1.3979886140935704e-06	0.000198511166253	BCL2
161	gastritis h pylori	C0744310	1	29	1.3979886140935704e-06	0.000199751861042	BCL2
162	Generalized anxiety disorder	C0270549	1	30	1.4978483277028332e-06	0.000200992555831	BCL2
163	Gastric Mucosa-Associated Lymphoid Tissue Lymphoma	C1333782	1	30	1.4978483277028332e-06	0.00020223325062	BCL2
164	Monocytosis	C0085702	1	31	1.6011336557708589e-06	0.000203473945409	BCL2
165	Chronic leukemia	C1279296	1	31	1.6011336557708589e-06	0.000204714640199	BCL2
166	Hemorrhagic disorder due to intrinsic circulating anticoagulants	C0019087	1	32	1.7078444612961263e-06	0.000205955334988	TUBB1
167	Normal pressure hydrocephalus	C0020258	1	33	1.818038363521346e-06	0.000207196029777	BCL2
168	Circumscribed scleroderma	C0036420	1	33	1.818038363521346e-06	0.000208436724566	BCL2
169	Superinfection	C0038826	1	33	1.818038363521346e-06	0.000209677419355	BCL2
170	Uterine leiomyosarcoma	C0280631	1	33	1.818038363521346e-06	0.000210918114144	BCL2
171	Follicular neoplasm	C0474808	1	33	1.818038363521346e-06	0.000212158808933	BCL2
172	Complete hydatidiform mole	C0678213	1	33	1.818038363521346e-06	0.000213399503722	BCL2
173	Aggressive Non-Hodgkin Lymphoma	C1332225	1	33	1.818038363521346e-06	0.000214640198511	BCL2
174	Cervix Diseases	C0007867	1	34	1.931686341549721e-06	0.0002158808933	BCL2
175	Fatal infectious mononucleosis	C0021345	1	34	1.931686341549721e-06	0.000217121588089	BCL2
176	Lichen planus pemphigoides	C0023646	1	34	1.931686341549721e-06	0.000218362282878	BCL2
177	Meningitis, Pneumococcal	C0025295	1	34	1.931686341549721e-06	0.000219602977667	BCL2
178	Malignant neoplasm of oropharynx	C0153382	1	34	1.931686341549721e-06	0.000220843672457	BCL2
179	Comedone	C0221228	1	34	1.931686341549721e-06	0.000222084367246	BCL2
180	Prostate cancer recurrent	C0278838	1	34	1.931686341549721e-06	0.000223325062035	BCL2
181	Hypervolemia	C0546817	1	34	1.931686341549721e-06	0.000224565756824	BCL2
182	Dermatitis Herpetiformis	C0011608	1	35	2.0487006666680685e-06	0.000225806451613	BCL2
183	Complete trisomy 18 syndrome	C0152096	1	36	2.1692553230368006e-06	0.000227047146402	BCL2
184	AIDS related complex	C0001857	1	37	2.29326331080415e-06	0.000228287841191	BCL2
185	Condylomata Acuminata	C0009663	1	37	2.29326331080415e-06	0.00022952853598	BCL2
186	Folic Acid Deficiency	C0016412	1	37	2.29326331080415e-06	0.000230769230769	BCL2
187	Odontogenic neoplasm	C0028880	1	37	2.29326331080415e-06	0.000232009925558	BCL2
188	Mediastinal (Thymic) Large B-Cell Lymphoma	C1292754	1	37	2.29326331080415e-06	0.000233250620347	BCL2
189	Lymphoma, AIDS-Related	C0085090	1	38	2.4206366966428305e-06	0.000234491315136	BCL2
190	Lymphosarcoma	C3714542	1	38	2.4206366966428305e-06	0.000235732009926	BCL2
191	Diffuse Astrocytoma	C0280785	1	39	2.5514625733302765e-06	0.000236972704715	BCL2
192	Prolymphocytic Leukemia	C0023486	1	40	2.6857985961914466e-06	0.000238213399504	BCL2
193	Prostatic Diseases	C0033575	1	40	2.6857985961914466e-06	0.000239454094293	BCL2
194	Small Lymphocytic Lymphoma	C0855095	1	40	2.6857985961914466e-06	0.000240694789082	BCL2
195	Arteriovenous fistula	C0003855	1	41	2.823499724247114e-06	0.000241935483871	BCL2
196	Bronchogenic Carcinoma	C0007121	1	41	2.823499724247114e-06	0.00024317617866	BCL2
197	Rabies (disorder)	C0034494	1	41	2.823499724247114e-06	0.000244416873449	BCL2
198	Neoplasm of the tongue	C0040411	1	41	2.823499724247114e-06	0.000245657568238	BCL2
199	Mixed cryoglobulinemia	C0543697	1	42	2.964651906967042e-06	0.000246898263027	BCL2
200	Gestational trophoblastic disease	C1135868	1	42	2.964651906967042e-06	0.000248138957816	BCL2
201	Thrombotic Microangiopathies	C2717961	1	42	2.964651906967042e-06	0.000249379652605	BCL2
202	Precursor cell lymphoblastic lymphoma	C0079748	1	44	3.257368667908267e-06	0.000250620347395	BCL2
203	Primary central nervous system lymphoma	C0280803	1	44	3.257368667908267e-06	0.000251861042184	BCL2
204	Cervical intraepithelial neoplasia grade 1	C0349458	1	44	3.257368667908267e-06	0.000253101736973	BCL2
205	Primary Carcinoma	C1335475	1	44	3.257368667908267e-06	0.000254342431762	BCL2
206	Fuchs' Endothelial Dystrophy	C0016781	1	45	3.408903267887453e-06	0.000255583126551	BCL2
207	Reticulosarcoma	C0024302	1	45	3.408903267887453e-06	0.00025682382134	BCL2
208	Thromboangiitis Obliterans	C0040021	1	45	3.408903267887453e-06	0.000258064516129	BCL2
209	Varicose Ulcer	C0042344	1	45	3.408903267887453e-06	0.000259305210918	BCL2
210	Learning Disorders	C0023186	1	47	3.7221782833718464e-06	0.000260545905707	BCL2
211	Li-Fraumeni syndrome	C0085390	1	47	3.7221782833718464e-06	0.000261786600496	BCL2
212	Trisomy 12	C0432408	1	47	3.7221782833718464e-06	0.000263027295285	BCL2
213	Neck Neoplasms	C0027533	1	48	3.884063198844601e-06	0.000264267990074	BCL2
214	Neoplasm of the gallbladder	C0016978	1	49	4.049368985681312e-06	0.000265508684864	BCL2
215	Pleuritis	C0032231	1	49	4.049368985681312e-06	0.000266749379653	BCL2
216	Ganglioneuroblastoma	C0206718	1	49	4.049368985681312e-06	0.000267990074442	BCL2
217	Cervical intraepithelial neoplasia grade 2	C0349459	1	49	4.049368985681312e-06	0.000269230769231	BCL2
218	Splenic Marginal Zone B-Cell Lymphoma	C0349632	1	49	4.049368985681312e-06	0.00027047146402	BCL2
219	Atypical teratoid/rhabdoid tumor	C1266184	1	49	4.049368985681312e-06	0.000271712158809	BCL2
220	Severe congenital neutropenia	C1853118	1	50	4.2180367135769e-06	0.000272952853598	BCL2
221	Malignant neoplasm of female breast	C0235653	1	51	4.3902114797989e-06	0.000274193548387	BCL2
222	Leukoplakia	C0023531	1	52	4.565835154402009e-06	0.000275434243176	BCL2
223	Squamous intraepithelial lesion	C0333873	1	52	4.565835154402009e-06	0.000276674937965	BCL2
224	Urticaria Pigmentosa	C0042111	1	53	4.744820149449325e-06	0.000277915632754	BCL2
225	Cervical Adenocarcinoma	C0279672	1	53	4.744820149449325e-06	0.000279156327543	BCL2
226	Carcinoma in situ of uterine cervix	C0851140	1	53	4.744820149449325e-06	0.000280397022333	BCL2
227	Drug Resistant Epilepsy	C1096063	1	53	4.744820149449325e-06	0.000281637717122	BCL2
228	Gorlin syndrome	C0004779	1	54	4.927340029659e-06	0.000282878411911	BCL2
229	Female Breast Carcinoma	C0007104	1	54	4.927340029659e-06	0.0002841191067	BCL2
230	Endometrial Hyperplasia	C0014173	1	54	4.927340029659e-06	0.000285359801489	BCL2
231	Tongue Carcinoma	C0558353	1	54	4.927340029659e-06	0.000286600496278	BCL2
232	Abnormality of the pleura	C4025726	1	54	4.927340029659e-06	0.000287841191067	BCL2
233	Refractory anaemia with excess blasts	C0002894	1	55	5.113337327888878e-06	0.000289081885856	BCL2
234	Carcinoma, Neuroendocrine	C0206695	1	55	5.113337327888878e-06	0.000290322580645	BCL2
235	Memory Disorders	C0025261	1	56	5.302723795952424e-06	0.000291563275434	BCL2
236	Necrosis	C0027540	1	56	5.302723795952424e-06	0.000292803970223	BCL2
237	Multiple endocrine neoplasia, type 4	C0027662	1	56	5.302723795952424e-06	0.000294044665012	BCL2
238	Sicca Syndrome	C0086981	1	56	5.302723795952424e-06	0.000295285359801	BCL2
239	Endometriosis of uterus	C0341858	1	56	5.302723795952424e-06	0.000296526054591	BCL2
240	Aicardi Goutieres syndrome 1	C0796126	1	56	5.302723795952424e-06	0.00029776674938	BCL2
241	Diabetic Cardiomyopathies	C0853897	1	56	5.302723795952424e-06	0.000299007444169	BCL2
242	Autoimmune lymphoproliferative syndrome, type 2	C1328840	1	56	5.302723795952424e-06	0.000300248138958	BCL2
243	Photoreceptor degeneration	C1998028	1	56	5.302723795952424e-06	0.000301488833747	BCL2
244	Mastocytosis	C0024899	1	57	5.495528788479476e-06	0.000302729528536	BCL2
245	Medullary carcinoma	C0206693	1	57	5.495528788479476e-06	0.000303970223325	BCL2
246	Malignant Fibrous Histiocytoma	C0334463	1	57	5.495528788479476e-06	0.000305210918114	BCL2
247	Glucocorticoid resistance, generalized	C1841972	1	57	5.495528788479476e-06	0.000306451612903	BCL2
248	Angioimmunoblastic Lymphadenopathy	C0020981	1	58	5.6917804410749895e-06	0.000307692307692	BCL2
249	Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease	C0221013	1	58	5.6917804410749895e-06	0.000308933002481	BCL2
250	Oropharyngeal squamous cell carcinoma	C0280313	1	58	5.6917804410749895e-06	0.00031017369727	BCL2
251	Neoplasm of the parathyroid gland	C0030521	1	59	5.891508127575662e-06	0.00031141439206	BCL2
252	cancer recurrence	C0920420	1	59	5.891508127575662e-06	0.000312655086849	BCL2
253	Oropharyngeal Carcinoma	C2349952	1	60	6.094653053345667e-06	0.000313895781638	BCL2
254	Memory Loss	C0002622	1	61	6.301302119759988e-06	0.000315136476427	BCL2
255	Adenomatous polyp of colon	C0850572	1	61	6.301302119759988e-06	0.000316377171216	BCL2
256	Ovarian adenocarcinoma	C0948216	1	61	6.301302119759988e-06	0.000317617866005	BCL2
257	Infiltrating Cervical Carcinoma	C1334177	1	61	6.301302119759988e-06	0.000318858560794	BCL2
258	Other specified disorders of breast	C0006145	1	62	6.5113393392657315e-06	0.000320099255583	BCL2
259	Childhood Leukemia	C1332977	1	62	6.5113393392657315e-06	0.000321339950372	BCL2
260	Hydatidiform mole, recurrent, 1, 231090 (3)	C3463897	1	62	6.5113393392657315e-06	0.000322580645161	BCL2
261	Diamond-Blackfan anemia	C1260899	1	63	6.724763691012825e-06	0.00032382133995	BCL2
262	Persistent infection	C1264606	1	63	6.724763691012825e-06	0.000325062034739	BCL2
263	Refractory cancer	C0677936	1	64	6.941720409159302e-06	0.000326302729529	BCL2
264	Chronic lung disease	C0746102	1	64	6.941720409159302e-06	0.000327543424318	BCL2
265	Bipolar I disorder	C0853193	1	64	6.941720409159302e-06	0.000328784119107	BCL2
266	Ameloblastoma	C0002448	1	65	7.162064452836958e-06	0.000330024813896	BCL2
267	Atypical nevus	C0205748	1	65	7.162064452836958e-06	0.000331265508685	BCL2
268	Fibroadenoma of the breast	C0178421	1	66	7.385910543500351e-06	0.000332506203474	BCL2
269	Renal dysplasia	C0235831	1	66	7.385910543500351e-06	0.000333746898263	BCL2
270	Hypoxia-Ischemia, Brain	C0752308	1	66	7.385910543500351e-06	0.000334987593052	BCL2
271	Histiocytosis, Langerhans-Cell	C0019621	1	68	7.843849719746387e-06	0.000336228287841	BCL2
272	Hepatosplenic schistosomiasis	C0036323	1	68	7.843849719746387e-06	0.00033746898263	BCL2
273	Microalbuminuria	C0730345	1	68	7.843849719746387e-06	0.000338709677419	BCL2
274	Neoplasms, Intracranial	C1527390	1	68	7.843849719746387e-06	0.000339950372208	BCL2
275	Malformation of cortical development	C1955869	1	68	7.843849719746387e-06	0.000341191066998	BCL2
276	Lymphocytosis	C0024282	1	69	8.077999647526646e-06	0.000342431761787	BCL2
277	Shock, Septic	C0036974	1	69	8.077999647526646e-06	0.000343672456576	BCL2
278	Mitochondrial DNA depletion syndrome, hepatocerebral form	C0342782	1	69	8.077999647526646e-06	0.000344913151365	BCL2
279	Nephronophthisis	C0687120	1	69	8.077999647526646e-06	0.000346153846154	BCL2
280	Skin lesion	C0037284	1	70	8.315593046037684e-06	0.000347394540943	BCL2
281	Nasopharyngeal cancer recurrent	C0153392	1	70	8.315593046037684e-06	0.000348635235732	BCL2
282	Acute Lung Injury	C0242488	1	71	8.556658727676414e-06	0.000349875930521	BCL2
283	{Pemphigoid, susceptibility to} (2)	C0030805	1	72	8.80113854107023e-06	0.00035111662531	BCL2
284	Miller Dieker syndrome	C0265219	1	72	8.80113854107023e-06	0.000352357320099	BCL2
285	Viral hepatitis	C0042721	1	73	9.049031858165968e-06	0.000353598014888	BCL2
286	Embryonal neoplasm	C0027654	1	74	9.30042552049759e-06	0.000354838709677	BCL2
287	Pathologic Neovascularization	C0027686	1	74	9.30042552049759e-06	0.000356079404467	BCL2
288	Oral leukoplakia	C0023532	1	75	9.55523264145608e-06	0.000357320099256	BCL2
289	Postoperative Complications	C0032787	1	75	9.55523264145608e-06	0.000358560794045	BCL2
290	Pleural Effusion, Malignant	C0080032	1	75	9.55523264145608e-06	0.000359801488834	BCL2
291	Adenovirus Infections	C0001486	1	76	9.813394378888063e-06	0.000361042183623	BCL2
292	Pulmonary edema	C0034063	1	77	1.0075113246688083e-05	0.000362282878412	BCL2
293	Chronic gastritis	C0085695	1	77	1.0075113246688083e-05	0.000363523573201	BCL2
294	Brain Infarction	C0751955	1	77	1.0075113246688083e-05	0.00036476426799	BCL2
295	Salivary gland neoplasm	C0036095	1	78	1.0340274201436905e-05	0.000366004962779	BCL2
296	Amyotrophic Lateral Sclerosis, Sporadic	C1862941	1	78	1.0340274201436905e-05	0.000367245657568	BCL2
297	Scar conditions and fibrosis of skin	C0241158	1	79	1.0608846362725188e-05	0.000368486352357	BCL2
298	Metaplasia	C0025568	1	80	1.0880917691968861e-05	0.000369727047146	BCL2
299	Benign melanocytic nevus	C1456781	1	80	1.0880917691968861e-05	0.000370967741935	BCL2
300	Rash and Dermatitis Adverse Event Associated with Chemoradiation	C1559154	1	80	1.0880917691968861e-05	0.000372208436725	BCL2
301	Hormone refractory prostate cancer	C1328504	1	81	1.1156371296117129e-05	0.000373449131514	BCL2
302	Hydatidiform mole, recurrent, 2	C0020217	1	82	1.143523601676577e-05	0.000374689826303	BCL2
303	Chlamydia Infections	C0008149	1	83	1.1717598259908257e-05	0.000375930521092	BCL2
304	granulosa cell tumor	C0018206	1	83	1.1717598259908257e-05	0.000377171215881	BCL2
305	Undifferentiated carcinoma	C0205698	1	83	1.1717598259908257e-05	0.00037841191067	BCL2
306	Lichen Planus, Oral	C0206139	1	83	1.1717598259908257e-05	0.000379652605459	BCL2
307	Infarction, Middle Cerebral Artery	C0740392	1	83	1.1717598259908257e-05	0.000380893300248	BCL2
308	Renal ischaemia	C0920646	1	83	1.1717598259908257e-05	0.000382133995037	BCL2
309	CNS infection	C0007684	1	84	1.2003400531312991e-05	0.000383374689826	BCL2
310	Nasopharyngeal Neoplasms	C0027439	1	84	1.2003400531312991e-05	0.000384615384615	BCL2
311	Mucinous Adenocarcinoma	C0007130	1	86	1.258532180525851e-05	0.000385856079404	BCL2
312	Cholera	C0008354	1	86	1.258532180525851e-05	0.000387096774194	BCL2
313	Pterygium	C0033999	1	86	1.258532180525851e-05	0.000388337468983	BCL2
314	Soft Tissue Neoplasms	C0037579	1	86	1.258532180525851e-05	0.000389578163772	BCL2
315	Severe Sepsis	C1719672	1	86	1.258532180525851e-05	0.000390818858561	BCL2
316	Herpes NOS	C0019340	1	87	1.2881498632988375e-05	0.00039205955335	BCL2
317	Carcinoid tumor no ICD-O subtype	C0334299	1	87	1.2881498632988375e-05	0.000393300248139	BCL2
318	Necrotizing Enterocolitis	C4082937	1	88	1.3181027265329881e-05	0.000394540942928	BCL2
319	Plasmacytoma	C0032131	1	89	1.3484022141185825e-05	0.000395781637717	BCL2
320	Thyroid adenoma	C0151468	1	89	1.3484022141185825e-05	0.000397022332506	BCL2
321	Adrenocortical adenoma	C0206667	1	89	1.3484022141185825e-05	0.000398263027295	BCL2
322	Contact Dermatitis	C0011616	1	90	1.379051355998584e-05	0.000399503722084	BCL2
323	Oral Cavity Carcinoma	C0151546	1	90	1.379051355998584e-05	0.000400744416873	BCL2
324	Adult Acute Myeloblastic Leukemia	C0220615	1	90	1.379051355998584e-05	0.000401985111663	BCL2
325	Thyroid associated opthalmopathies	C0339143	1	90	1.379051355998584e-05	0.000403225806452	BCL2
326	High-Grade Prostatic Intraepithelial Neoplasia	C1168327	1	90	1.379051355998584e-05	0.000404466501241	BCL2
327	Actinic keratosis	C0022602	1	91	1.4100413066597817e-05	0.00040570719603	BCL2
328	Neuromuscular Diseases	C0027868	1	91	1.4100413066597817e-05	0.000406947890819	BCL2
329	Skin nodule	C0037287	1	92	1.44137501306707e-05	0.000408188585608	BCL2
330	Lymphedema, primary, with myelodysplasia	C0024236	1	93	1.4730494924730664e-05	0.000409429280397	BCL2
331	Merkel cell carcinoma	C0007129	1	94	1.5050734242350039e-05	0.000410669975186	BCL2
332	Adenocarcinoma, Clear Cell	C0206681	1	94	1.5050734242350039e-05	0.000411910669975	BCL2
333	Inflammatory Breast Carcinoma	C0278601	1	94	1.5050734242350039e-05	0.000413151364764	BCL2
334	Cerebral palsy, spastic quadriplegic, 3	C0007789	1	95	1.5374410264334948e-05	0.000414392059553	BCL2
335	Skin carcinoma	C0699893	1	95	1.5374410264334948e-05	0.000415632754342	BCL2
336	Oxyphilic Adenoma	C0949541	1	95	1.5374410264334948e-05	0.000416873449132	BCL2
337	Waldenstrom macroglobulinemia	C0024419	1	96	1.5701522021571712e-05	0.000418114143921	BCL2
338	Endotoxemia	C0376618	1	96	1.5701522021571712e-05	0.00041935483871	BCL2
339	Vesicular Stomatitis	C0266999	1	97	1.6032127656218087e-05	0.000420595533499	BCL2
340	Multicystic kidney dysplasia	C3714581	1	97	1.6032127656218087e-05	0.000421836228288	BCL2
341	Interstitial fibrosis	C3887486	1	97	1.6032127656218087e-05	0.000423076923077	BCL2
342	Advanced cancer	C0877373	1	100	1.704441184435801e-05	0.000424317617866	BCL2
343	Leukemia, B-Cell	C2004493	1	100	1.704441184435801e-05	0.000425558312655	BCL2
344	Melanoma, B16	C0004565	1	102	1.7736567247017554e-05	0.000426799007444	BCL2
345	Liver Cirrhosis, Alcoholic	C0023891	1	103	1.8087752222895048e-05	0.000428039702233	BCL2
346	Endometrial adenocarcinoma	C1153706	1	103	1.8087752222895048e-05	0.000429280397022	BCL2
347	Adult Acute Lymphocytic Leukemia	C0751606	1	104	1.8442429544518468e-05	0.000430521091811	BCL2
348	Neoplasm of the rectum	C0034885	1	105	1.8800511141892073e-05	0.0004317617866	BCL2
349	High grade serous carcinoma	C0206701	1	105	1.8800511141892073e-05	0.00043300248139	BCL2
350	Rhabdoid Tumor of the Kidney	C0854917	1	105	1.8800511141892073e-05	0.000434243176179	BCL2
351	Posttraumatic stress disorder	C0038436	1	106	1.9162026068331173e-05	0.000435483870968	BCL2
352	precancerous lesions	C0940937	1	106	1.9162026068331173e-05	0.000436724565757	BCL2
353	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	C0023485	1	107	1.9527060307167332e-05	0.000437965260546	BCL2
354	Middle Cerebral Artery Occlusion	C0740391	1	107	1.9527060307167332e-05	0.000439205955335	BCL2
355	Clear-cell metastatic renal cell carcinoma	C2931852	1	108	1.989549923175904e-05	0.000440446650124	BCL2
356	Mixed Salivary Gland Tumor	C0026277	1	109	2.0267369324811213e-05	0.000441687344913	BCL2
357	Glomerulosclerosis, Focal Segmental	C0178664	1	109	2.0267369324811213e-05	0.000442928039702	BCL2
358	tumor vasculature	C1658953	1	109	2.0267369324811213e-05	0.000444168734491	BCL2
359	Hairy Cell Leukemia	C0023443	1	110	2.064273032520436e-05	0.00044540942928	BCL2
360	Skin Carcinogenesis	C1519346	1	110	2.064273032520436e-05	0.000446650124069	BCL2
361	Neoplasm of the adrenal gland	C0001624	1	111	2.1021464750359264e-05	0.000447890818859	BCL2
362	Dermatitis, Allergic Contact	C0162820	1	111	2.1021464750359264e-05	0.000449131513648	BCL2
363	CNS disorder	C0007682	1	113	2.1789372304792387e-05	0.000450372208437	BCL2
364	Adrenal insufficiency	C0001623	1	114	2.2178458896848774e-05	0.000451612903226	BCL2
365	early pregnancy	C0747845	1	114	2.2178458896848774e-05	0.000452853598015	BCL2
366	Multicystic renal dysplasia, bilateral	C1840451	1	114	2.2178458896848774e-05	0.000454094292804	BCL2
367	Chronic atrophic gastritis	C0017154	1	116	2.296692214764917e-05	0.000455334987593	BCL2
368	Gastric ulcer	C0038358	1	116	2.296692214764917e-05	0.000456575682382	BCL2
369	Meningitis	C0497299	1	116	2.296692214764917e-05	0.000457816377171	BCL2
370	Mammary Ductal Carcinoma	C0021367	1	117	2.3366385501377707e-05	0.00045905707196	BCL2
371	Knee osteoarthritis	C0409959	1	118	2.3769279582586123e-05	0.000460297766749	BCL2
372	Xeroderma pigmentosum, group E	C0043346	1	119	2.4175544493520995e-05	0.000461538461538	BCL2
373	Squamous cell carcinoma of tongue	C0349566	1	120	2.4585296637180676e-05	0.000462779156328	BCL2
374	Bilateral cataracts (disorder)	C3277059	1	120	2.4585296637180676e-05	0.000464019851117	BCL2
375	Primary Effusion Lymphoma	C1292753	1	121	2.4998506627182948e-05	0.000465260545906	BCL2
376	Liposarcoma	C0023827	1	122	2.5415174152110254e-05	0.000466501240695	BCL2
377	Peripheral T-Cell Lymphoma	C0079774	1	122	2.5415174152110254e-05	0.000467741935484	BCL2
378	Peptic ulcer	C0030920	1	123	2.5835241327598624e-05	0.000468982630273	BCL2
379	Carcinoma, Endometrioid	C0206687	1	123	2.5835241327598624e-05	0.000470223325062	BCL2
380	Lymphadenopathy	C0497156	1	124	2.6258736079864953e-05	0.000471464019851	BCL2
381	Impotence	C0242350	1	126	2.711618265094362e-05	0.00047270471464	BCL2
382	Common variable immunodeficiency 2	C0009447	1	130	2.8872227810117224e-05	0.000473945409429	BCL2
383	Abnormality of the lymph nodes	C0149727	1	130	2.8872227810117224e-05	0.000475186104218	BCL2
384	Transitional cell carcinoma of the bladder	C0279680	1	132	2.977093820355492e-05	0.000476426799007	BCL2
385	Lewy Body Disease	C0752347	1	132	2.977093820355492e-05	0.000477667493797	BCL2
386	Intraepithelial Neoplasia	C0878500	1	132	2.977093820355492e-05	0.000478908188586	BCL2
387	Malignant neoplasm of larynx	C0007107	1	133	3.0225474787592965e-05	0.000480148883375	BCL2
388	Metastatic malignant neoplasm to brain	C0220650	1	133	3.0225474787592965e-05	0.000481389578164	BCL2
389	Thyroiditis	C0040147	1	134	3.068343696577269e-05	0.000482630272953	BCL2
390	Laryngeal Squamous Cell Carcinoma	C0280324	1	134	3.068343696577269e-05	0.000483870967742	BCL2
391	 {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against} (3)	C0751688	1	134	3.068343696577269e-05	0.000485111662531	BCL2
392	Acute hepatic failure	C0162557	1	135	3.1144823532280874e-05	0.00048635235732	BCL2
393	Anaplastic Oligodendroglioma	C0334590	1	135	3.1144823532280874e-05	0.000487593052109	BCL2
394	Leiomyosarcoma	C0023269	1	136	3.160972146987184e-05	0.000488833746898	BCL2
395	Liver Neoplasms, Experimental	C0023904	1	136	3.160972146987184e-05	0.000490074441687	BCL2
396	Motor Neuron Disease	C0085084	1	136	3.160972146987184e-05	0.000491315136476	BCL2
397	Pleural effusion	C0032227	1	137	3.207801539251154e-05	0.000492555831266	BCL2
398	Anaplastic astrocytoma	C0334579	1	137	3.207801539251154e-05	0.000493796526055	BCL2
399	Testicular Neoplasms	C0039590	1	139	3.302490285894688e-05	0.000495037220844	BCL2
400	Adrenoleukodystrophy	C0162309	1	139	3.302490285894688e-05	0.000496277915633	BCL2
401	Mild cognitive impairment	C1270972	1	141	3.398557059475227e-05	0.000497518610422	BCL2
402	Mammary Tumorigenesis	C1512981	1	141	3.398557059475227e-05	0.000498759305211	BCL2
403	Disorder characterized by eosinophilia	C1636667	1	141	3.398557059475227e-05	0.0005	BCL2
404	Hematological Disease	C0018939	1	143	3.496004572445255e-05	0.000501240694789	BCL2
405	Hyperplasia	C0020507	1	143	3.496004572445255e-05	0.000502481389578	BCL2
406	Eosinophilic disorder	C1306759	1	143	3.496004572445255e-05	0.000503722084367	BCL2
407	Neoplastic Cell Transformation	C0007621	1	144	3.54524167303083e-05	0.000504962779156	BCL2
408	Neurodegeneration with brain iron accumulation	C0027746	1	144	3.54524167303083e-05	0.000506203473945	BCL2
409	Chronic liver disease	C0341439	1	144	3.54524167303083e-05	0.000507444168734	BCL2
410	Intestinal Neoplasms	C0021841	1	145	3.594829614239625e-05	0.000508684863524	BCL2
411	Sporadic Breast Carcinoma	C1336076	1	147	3.695029182937404e-05	0.000509925558313	BCL2
412	invasive cancer	C0677898	1	150	3.847913019272564e-05	0.000511166253102	BCL2
413	Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation	C0751690	1	151	3.899562300591075e-05	0.000512406947891	BCL2
414	androgen independent prostate cancer	C1654637	1	156	4.162972448384927e-05	0.00051364764268	BCL2
415	Hemangioma	C0018916	1	157	4.21669345356257e-05	0.000514888337469	BCL2
416	Thrombosis	C0040053	1	157	4.21669345356257e-05	0.000516129032258	TUBB1
417	Glomerulopathy	C0268731	1	159	4.3251580463143924e-05	0.000517369727047	BCL2
418	Adenocarcinoma of prostate	C0007112	1	161	4.435001183333842e-05	0.000518610421836	BCL2
419	Progressive Neoplastic Disease	C0677932	1	161	4.435001183333842e-05	0.000519851116625	BCL2
420	Progressive cGVHD	C3539781	1	161	4.435001183333842e-05	0.000521091811414	BCL2
421	Disseminated Malignant Neoplasm	C0346957	1	162	4.4904339779439084e-05	0.000522332506203	BCL2
422	Acquired Immunodeficiency Syndrome	C0001175	1	163	4.5462140554786146e-05	0.000523573200993	BCL2
423	Myeloproliferative disorder (2)	C1292778	1	165	4.6588167262995306e-05	0.000524813895782	BCL2
424	Squamous cell carcinoma of the skin	C0553723	1	166	4.715627542650758e-05	0.000526054590571	BCL2
425	Encephalitis	C0014038	1	167	4.7727914222694956e-05	0.00052729528536	BCL2
426	Lymphatic Metastasis	C0024232	1	168	4.8302941051403536e-05	0.000528535980149	BCL2
427	Malignant neoplasm of gallbladder	C0153452	1	168	4.8302941051403536e-05	0.000529776674938	BCL2
428	Hematopoietic Neoplasms	C0376544	1	168	4.8302941051403536e-05	0.000531017369727	BCL2
429	Tumor necrosis	C0333516	1	170	4.946332425004307e-05	0.000532258064516	BCL2
430	Uterine Cervical Neoplasms	C0007873	1	171	5.0048680020009506e-05	0.000533498759305	BCL2
431	Amyotrophic lateral sclerosis type 1	C1862939	1	171	5.0048680020009506e-05	0.000534739454094	BCL2
432	Aplastic anemia	C0002874	1	172	5.0637509599438246e-05	0.000535980148883	BCL2
433	Borderline Personality Disorder	C0006012	1	172	5.0637509599438246e-05	0.000537220843672	BCL2
434	Nevus	C0497388	1	174	5.182543739923329e-05	0.000538461538462	BCL2
435	Eosinophilia	C0014457	1	175	5.2424592807520654e-05	0.000539702233251	BCL2
436	Thymoma	C0040100	1	176	5.302716312394207e-05	0.00054094292804	BCL2
437	Lymphoma, Large-Cell, Follicular	C0079745	1	176	5.302716312394207e-05	0.000542183622829	BCL2
438	Keloid	C0022548	1	178	5.424268360232354e-05	0.000543424317618	BCL2
439	Synovial sarcoma	C0039101	1	178	5.424268360232354e-05	0.000544665012407	BCL2
440	Trisomy	C0041107	1	179	5.485557666329299e-05	0.000545905707196	BCL2
441	Non-Malignant Ascites Adverse Event	C1559271	1	181	5.6091713865003e-05	0.000547146401985	BCL2
442	Synovial Cyst	C0085648	1	182	5.671498652026763e-05	0.000548387096774	BCL2
443	Tumor Initiation	C0598935	1	182	5.671498652026763e-05	0.000549627791563	BCL2
444	Carcinoid tumor	C0007095	1	183	5.734166996951284e-05	0.000550868486352	BCL2
445	Vasculitis	C0042384	1	183	5.734166996951284e-05	0.000552109181141	BCL2
446	Kaposi's sarcoma	C0036220	1	184	5.7971764350850385e-05	0.000553349875931	BCL2
447	Laryngeal carcinoma	C0595989	1	184	5.7971764350850385e-05	0.00055459057072	BCL2
448	Melanocytic nevus	C0027962	1	185	5.860532625234782e-05	0.000555831265509	BCL2
449	Status epilepticus	C0038220	1	185	5.860532625234782e-05	0.000557071960298	BCL2
450	Spinal muscular atrophy with congenital bone fractures 2	C0026847	1	187	5.9882854571813304e-05	0.000558312655087	BCL2
451	Adenocarcinoma of the large intestine	C1319315	1	189	6.117404977357133e-05	0.000559553349876	BCL2
452	Well Differentiated Oligodendroglioma	C0751396	1	191	6.247911190560007e-05	0.000560794044665	BCL2
453	Dilated cardiomyopathy 1A	C1449563	1	191	6.247911190560007e-05	0.000562034739454	BCL2
454	Epilepsy, Temporal Lobe	C0014556	1	192	6.313674128377578e-05	0.000563275434243	BCL2
455	Squamous cell carcinoma of lung	C0149782	1	192	6.313674128377578e-05	0.000564516129032	BCL2
456	Gallbladder Carcinoma	C0235782	1	192	6.313674128377578e-05	0.000565756823821	BCL2
457	Primary cutaneous marginal zone B-cell lymphoma	C0242647	1	193	6.37978649281612e-05	0.00056699751861	BCL2
458	Acute Erythroblastic Leukemia	C0023440	1	195	6.513048068168548e-05	0.0005682382134	BCL2
459	Myocardial Reperfusion Injury	C0027055	1	196	6.580188583815705e-05	0.000569478908189	BCL2
460	Papilloma	C0030354	1	196	6.580188583815705e-05	0.000570719602978	BCL2
461	Chronic hepatitis	C0019189	1	197	6.647678268145718e-05	0.000571960297767	BCL2
462	Medullary thyroid carcinoma	C0238462	1	201	6.921081450073086e-05	0.000573200992556	BCL2
463	Death, Sudden, Cardiac	C0011065	1	203	7.059845141277332e-05	0.000574441687345	BCL2
464	Skeletal dysplasia	C0029422	1	206	7.270577567308756e-05	0.000575682382134	BCL2
465	Intraocular melanoma	C0220633	1	206	7.270577567308756e-05	0.000576923076923	BCL2
466	Mammary Neoplasms, Experimental	C0024668	1	207	7.341510256042572e-05	0.000578163771712	BCL2
467	Neoplasm, Residual	C0242596	1	208	7.41278334808193e-05	0.000579404466501	BCL2
468	Burkitt lymphoma	C0006413	1	210	7.556373557315865e-05	0.00058064516129	BCL2
469	Hypercholesterolemia, autosomal dominant, type B	C0020443	1	212	7.701336471344078e-05	0.000581885856079	BCL2
470	Cervical intraepithelial neoplasia (Cervical dysplasia)	C0206708	1	212	7.701336471344078e-05	0.000583126550868	BCL2
471	Abnormal platelet count	C0580317	1	212	7.701336471344078e-05	0.000584367245658	TUBB1
472	Benign neoplasm of other endocrine glands	C0086692	1	213	7.774336934607273e-05	0.000585607940447	BCL2
473	Meningioma, benign, no ICD-O subtype	C1762616	1	217	8.069769489171819e-05	0.000586848635236	BCL2
474	Epstein-Barr Virus Infections	C0149678	1	219	8.219555257593658e-05	0.000588089330025	BCL2
475	Hepatoblastoma	C0206624	1	220	8.294968218414134e-05	0.000589330024814	BCL2
476	Blast Phase	C0005699	1	221	8.37072136459227e-05	0.000590570719603	BCL2
477	Skin cancer	C0007114	1	222	8.446817155949304e-05	0.000591811414392	BCL2
478	Chondrosarcoma	C0008479	1	222	8.446817155949304e-05	0.000593052109181	BCL2
479	Testicular seminoma	C0036631	1	222	8.446817155949304e-05	0.00059429280397	BCL2
480	Anaplastic thyroid carcinoma	C0238461	1	223	8.52325884560523e-05	0.000595533498759	BCL2
481	Ductal Carcinoma	C1527349	1	223	8.52325884560523e-05	0.000596774193548	BCL2
482	Plaque, Atherosclerotic	C0011389	1	226	8.754648892161931e-05	0.000598014888337	BCL2
483	Primary pulmonary hypertension	C0152171	1	227	8.832470225927924e-05	0.000599255583127	BCL2
484	Malignant hyperthermia susceptibility type 5	C0015967	1	228	8.910628422231781e-05	0.000600496277916	BCL2
485	Anaplasia	C0002793	1	231	9.14718758949773e-05	0.000601736972705	BCL2
486	Invasive Ductal Breast Carcinoma	C1134719	1	231	9.14718758949773e-05	0.000602977667494	BCL2
487	Carcinoma, Papillary	C0007133	1	233	9.306613371262706e-05	0.000604218362283	BCL2
488	Disease Progression	C0242656	1	233	9.306613371262706e-05	0.000605459057072	BCL2
489	Abnormality of temperature regulation	C1832160	1	234	9.386841383762778e-05	0.000606699751861	BCL2
490	Lymphoproliferative disorder	C0024314	1	236	9.548336510212252e-05	0.00060794044665	BCL2
491	Nasal polyposis	C0027430	1	236	9.548336510212252e-05	0.000609181141439	BCL2
492	Ovarian Diseases	C0029928	1	236	9.548336510212252e-05	0.000610421836228	BCL2
493	Bronchopulmonary Dysplasia	C0006287	1	237	9.629600601646082e-05	0.000611662531017	BCL2
494	Gastritis	C0017152	1	237	9.629600601646082e-05	0.000612903225806	BCL2
495	Dermal atrophy	C0151514	1	237	9.629600601646082e-05	0.000614143920596	BCL2
496	Acute myocardial infarction	C0155626	1	237	9.629600601646082e-05	0.000615384615385	BCL2
497	Mitral stenosis	C0026269	1	238	9.711207085094653e-05	0.000616625310174	BCL2
498	Hypergranular promyelocytic leukemia	C2745900	1	238	9.711207085094653e-05	0.000617866004963	BCL2
499	Adenocarcinoma of colon	C0338106	1	240	9.875449964491523e-05	0.000619106699752	BCL2
500	Pleural Mesothelioma	C0812413	1	240	9.875449964491523e-05	0.000620347394541	BCL2
501	Abnormality of thrombocytes	C0151854	1	243	0.00010124400212130347	0.00062158808933	TUBB1
502	Myeloproliferative Disorders	C0027022	1	245	0.00010292094573993715	0.000622828784119	BCL2
503	Malignant gastrointestinal tract tumors	C0685938	1	251	0.00010803425855143711	0.000624069478908	BCL2
504	Lymphoid leukemia	C0023448	1	252	0.00010889854373330454	0.000625310173697	BCL2
505	Germ cell neoplasia	C0205851	1	252	0.00010889854373330454	0.000626550868486	BCL2
506	Neuroendocrine neoplasm	C0206754	1	252	0.00010889854373330454	0.000627791563275	BCL2
507	Thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis	C0040034	1	253	0.00010976627876990719	0.000629032258065	TUBB1
508	Fibrosarcoma	C0016057	1	254	0.00011063740338068673	0.000630272952854	BCL2
509	Recurrent bacterial infection	C0004623	1	255	0.00011151203304660129	0.000631513647643	BCL2
510	Neutropenia	C0027947	1	255	0.00011151203304660129	0.000632754342432	BCL2
511	Cutaneous T-cell lymphoma	C0079773	1	255	0.00011151203304660129	0.000633995037221	BCL2
512	Adenoma of large intestine	C1302401	1	257	0.00011327154937479378	0.00063523573201	BCL2
513	Microphthalmia syndromic 6	C0026010	1	258	0.00011415649242263459	0.000636476426799	BCL2
514	Hyperkeratosis	C0870082	1	258	0.00011415649242263459	0.000637717121588	BCL2
515	Pheochromocytoma	C0031511	1	259	0.00011504488176938832	0.000638957816377	BCL2
516	Azoospermia	C0004509	1	261	0.00011683197095502251	0.000640198511166	BCL2
517	Primary biliary cirrhosis	C0008312	1	263	0.00011863278484525175	0.000641439205955	BCL2
518	Anaplastic large cell lymphoma, ALK negative	C0206180	1	263	0.00011863278484525175	0.000642679900744	BCL2
519	Cutaneous malignant melanoma 3	C0151779	1	264	0.00011953846008316837	0.000643920595533	BCL2
520	Experimental Organism Basal Cell Carcinoma	C3811653	1	264	0.00011953846008316837	0.000645161290323	BCL2
521	Malignant mesothelioma	C0345967	1	266	0.00012135991613659858	0.000646401985112	BCL2
522	Glomerulonephritis, Membranous	C0017658	1	267	0.0001222758678102176	0.000647642679901	BCL2
523	Endometrial Neoplasms	C0014170	1	268	0.000123195235304685	0.00064888337469	BCL2
524	Acute kidney injury	C0022660	1	270	0.00012504429946957885	0.000650124069479	BCL2
525	Cerebral ischemia	C0917798	1	272	0.00012690710756202428	0.000651364764268	BCL2
526	Neoplasm Recurrence, Local	C0027643	1	277	0.00013162444029368725	0.000652605459057	BCL2
527	Choriocarcinoma	C0008497	1	279	0.00013353552068906538	0.000653846153846	BCL2
528	Epithelioma	C0553707	1	280	0.00013449616269956	0.000655086848635	BCL2
529	Clubfoot	C0009081	1	283	0.00013739896343267777	0.000656327543424	BCL2
530	polyps	C0032584	1	284	0.00013837336439326275	0.000657568238213	BCL2
531	Splenomegaly	C0038002	1	285	0.0001393512919969364	0.000658808933002	BCL2
532	Rectal Carcinoma	C0149978	1	286	0.0001403326295406071	0.000660049627792	BCL2
533	Gastric Adenocarcinoma	C0278701	1	286	0.0001403326295406071	0.000661290322581	BCL2
534	Retinal degeneration	C0035304	1	287	0.00014131746202417084	0.00066253101737	BCL2
535	Noninfiltrating Intraductal Carcinoma	C0007124	1	291	0.0001452910302418564	0.000663771712159	BCL2
536	Ischaemic cerebral infarction	C0007785	1	297	0.00015135470137839224	0.000665012406948	BCL2
537	Helicobacter pylori infection	C0850666	1	297	0.00015135470137839224	0.000666253101737	BCL2
538	Adenocarcinoma Of Esophagus	C0279628	1	300	0.00015443305865714407	0.000667493796526	BCL2
539	Leukopenia	C0023530	1	301	0.00015546602809490828	0.000668734491315	BCL2
540	Dementia familial British	C0011265	1	302	0.00015650251637167045	0.000669975186104	BCL2
541	T-cell lymphoma	C0079772	1	302	0.00015650251637167045	0.000671215880893	BCL2
542	Male infertility	C0021364	1	303	0.00015754241251664247	0.000672456575682	BCL2
543	Reperfusion Injury	C0035126	1	305	0.00015963247180927898	0.000673697270471	BCL2
544	Lupus Vulgaris	C0024131	1	307	0.00016173637893335258	0.000674937965261	BCL2
545	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11	C0026850	1	311	0.00016598543418588907	0.00067617866005	BCL2
546	Pulmonary arterial hypertension	C3203102	1	314	0.0001692083685763679	0.000677419354839	BCL2
547	Leiomyoma	C0023267	1	316	0.00017137421067048297	0.000678660049628	BCL2
548	Discoid lupus erythematosus	C0024138	1	319	0.0001746488227483134	0.000679900744417	BCL2
549	Huntington's chorea	C0020179	1	320	0.00017574724814362064	0.000681141439206	BCL2
550	Pancreatic adenocarcinoma	C0281361	1	320	0.00017574724814362064	0.000682382133995	BCL2
551	Recurrent tumor	C0521158	1	320	0.00017574724814362064	0.000683622828784	BCL2
552	Cancer Cell Growth	C1516170	1	320	0.00017574724814362064	0.000684863523573	BCL2
553	Pituitary Neoplasms	C0032019	1	321	0.0001768491001014061	0.000686104218362	BCL2
554	Mood Disorders	C0525045	1	322	0.00017795443882984152	0.000687344913151	BCL2
555	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	C0334634	1	327	0.00018353260113490588	0.00068858560794	BCL2
556	Uterine leiomyoma	C0042133	1	331	0.0001880571062916614	0.00068982630273	BCL2
557	Head and Neck Neoplasms	C0018671	1	333	0.00019034002674589434	0.000691066997519	BCL2
558	Pulmonary hypertension, neonatal, susceptibility to	C0020542	1	333	0.00019034002674589434	0.000692307692308	BCL2
559	Metastatic melanoma	C0278883	1	333	0.00019034002674589434	0.000693548387097	BCL2
560	Hypoxia	C0003130	1	335	0.00019263673158498307	0.000694789081886	BCL2
561	Hydrops, lactic acidosis, and sideroblastic anemia	C0013604	1	335	0.00019263673158498307	0.000696029776675	BCL2
562	Gastrointestinal stromal tumor	C0238198	1	340	0.00019843874032521303	0.000697270471464	BCL2
563	Carcinoma breast stage IV	C0278488	1	342	0.0002007836298542065	0.000698511166253	BCL2
564	Chronic kidney disease	C1561643	1	342	0.0002007836298542065	0.000699751861042	BCL2
565	Abnormality of fluid regulation	C2364164	1	346	0.00020551473030461231	0.000700992555831	BCL2
566	Abnormality of the spleen	C4025749	1	347	0.0002067061653484581	0.00070223325062	BCL2
567	Leukemia, T-cell acute lymphoblastoid (2)	C0023492	1	348	0.00020790102218470885	0.000703473945409	BCL2
568	Wilms Tumor	C0027708	1	352	0.00021271476069850692	0.000704714640199	BCL2
569	Renal neoplasm	C0022665	1	363	0.00022623668202248481	0.000705955334988	BCL2
570	Renal Insufficiency, Chronic	C0035078	1	363	0.00022623668202248481	0.000707196029777	BCL2
571	Fatigue	C0015672	1	365	0.0002287399910781973	0.000708436724566	BCL2
572	Clear cell renal cell carcinoma	C0279702	1	368	0.00023252074028268233	0.000709677419355	BCL2
573	Invasive breast carcinoma	C0853879	1	369	0.00023378787596350925	0.000710918114144	BCL2
574	T-cell acute lymphoblastic leukemias	C1961099	1	371	0.00023633253347332683	0.000712158808933	BCL2
575	Graves Disease	C0018213	1	374	0.00024017527894359958	0.000713399503722	BCL2
576	Thyroid Diseases	C0040128	1	376	0.00024275435291210012	0.000714640198511	BCL2
577	Hepatitis	C0019159	1	377	0.0002440490233224235	0.0007158808933	BCL2
578	Pulmonary Disease, Chronic Obstructive	C0024115	1	377	0.0002440490233224235	0.000717121588089	BCL2
579	Hereditary pancreatitis	C0238339	1	377	0.0002440490233224235	0.000718362282878	BCL2
580	Intrauterine growth retardation	C0015934	1	379	0.000246648712428299	0.000719602977667	BCL2
581	Rhabdomyosarcoma alveolar	C0035412	1	381	0.00024926218989251847	0.000720843672457	BCL2
582	Anxiety Disorders	C0003469	1	383	0.0002518894524738968	0.000722084367246	BCL2
583	Mesothelioma, malignant	C0025500	1	383	0.0002518894524738968	0.000723325062035	BCL2
584	B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1	C1292769	1	385	0.00025453049960943996	0.000724565756824	BCL2
585	Septicemia	C0036690	1	387	0.0002571852980309819	0.000725806451613	BCL2
586	Leukemia, Lymphocytic, Acute, L1	C0023452	1	388	0.00025851782402153134	0.000727047146402	BCL2
587	Lymphoma, Follicular	C0024301	1	389	0.0002598538735232303	0.000728287841191	BCL2
588	Urothelial Carcinoma	C0007138	1	391	0.00026253619837224296	0.00072952853598	BCL2
589	{Systemic lupus erythematosus, susceptibility to, 8} (2)	C0409974	1	393	0.00026523235284525715	0.000730769230769	BCL2
590	Disorders of Intracellular Cobalamin Metabolism	C0025517	1	394	0.0002665855855926713	0.000732009925558	BCL2
591	Familial adenomatous polyposis 1	C0032580	1	395	0.0002679422228271111	0.000733250620347	BCL2
592	Myelodysplastic syndrome	C3463824	1	399	0.00027340335151926354	0.000734491315136	BCL2
593	Cholangiocarcinoma	C0206698	1	401	0.0002761545510626684	0.000735732009926	BCL2
594	Malignant neoplasm of kidney	C0740457	1	401	0.0002761545510626684	0.000736972704715	BCL2
595	Cancer of the lower GI tract	C0006826	1	403	0.00027891953833636407	0.000738213399504	BCL2
596	Unipolar Depression	C0041696	1	406	0.0002830928372761221	0.000739454094293	BCL2
597	Behcet Syndrome	C0004943	1	407	0.0002844908779544575	0.000740694789082	BCL2
598	Hodgkin Disease	C0019829	1	409	0.0002872971383147682	0.000741935483871	BCL2
599	Malignant Glioma	C0555198	1	412	0.00029153246062996185	0.00074317617866	BCL2
600	Brain Ischemia	C0007786	1	415	0.0002957987390229677	0.000744416873449	BCL2
601	Hepatic fibrosis	C0239946	1	416	0.00029722768124740284	0.000745657568238	BCL2
602	Lip and Oral Cavity Carcinoma	C0220641	1	419	0.00030153530794041483	0.000746898263027	BCL2
603	Cancer of mouth	C0153381	1	420	0.00030297805032475367	0.000748138957816	BCL2
604	Benign Prostatic Hyperplasia	C1704272	1	423	0.000307326983025602	0.000749379652605	BCL2
605	Abnormality of the lymphatic system	C4021976	1	426	0.0003117068996926209	0.000750620347395	BCL2
606	Cancer of Head and Neck	C0278996	1	430	0.0003175949441507342	0.000751861042184	BCL2
607	Acute promyelocytic leukemia	C0023487	1	431	0.00031907557380228546	0.000753101736973	BCL2
608	Retinopathy	C0035309	1	434	0.00032353815392249796	0.000754342431762	BCL2
609	Glioblastoma multiforme	C1621958	1	434	0.00032353815392249796	0.000755583126551	BCL2
610	Celiac Disease	C0007570	1	436	0.0003265304023075677	0.00075682382134	BCL2
611	Neoplasm of the skin	C0037286	1	438	0.0003295363998504497	0.000758064516129	BCL2
612	Tumor Angiogenesis	C1519670	1	443	0.0003371117356459896	0.000759305210918	BCL2
613	Myopathy, scapulohumeroperoneal	C0026848	1	450	0.0003478617820334984	0.000760545905707	BCL2
614	Cystic Fibrosis	C0010674	1	451	0.0003494112730101362	0.000761786600496	BCL2
615	Papillary thyroid carcinoma	C0238463	1	451	0.0003494112730101362	0.000763027295285	BCL2
616	Meningioma	C0025286	1	452	0.0003509642137253799	0.000764267990074	BCL2
617	Thyroid cancer, nonmedullary, 4	C0007115	1	453	0.0003525205986453228	0.000765508684864	BCL2
618	Precancerous Conditions	C0032927	1	455	0.0003556437114405897	0.000766749379653	BCL2
619	Hepatitis C, Chronic	C0524910	1	455	0.0003556437114405897	0.000767990074442	BCL2
620	Hyperglycemia	C0020456	1	459	0.0003619311975714412	0.000769230769231	BCL2
621	Glaucoma, Angle-Closure	C0017601	1	461	0.00036509565334330585	0.00077047146402	BCL2
622	Visceromegaly	C0042782	1	461	0.00036509565334330585	0.000771712158809	BCL2
623	Non-Neoplastic Disorder	C1709246	1	461	0.00036509565334330585	0.000772952853598	BCL2
624	Triple Negative Breast Neoplasms	C3539878	1	461	0.00036509565334330585	0.000774193548387	BCL2
625	Urinary Bladder Neoplasms	C0005695	1	463	0.0003682738297461352	0.000775434243176	BCL2
626	Adult T-Cell Lymphoma/Leukemia	C0023493	1	469	0.00037789104745944435	0.000776674937965	BCL2
627	Pneumonia	C0032285	1	471	0.00038112427745040645	0.000777915632754	BCL2
628	Retinoblastoma	C0035335	1	473	0.00038437138510660773	0.000779156327543	BCL2
629	Eczema	C0013595	1	474	0.00038600003036748376	0.000780397022333	BCL2
630	Down Syndrome	C0013080	1	476	0.00038926780749948264	0.000781637717122	BCL2
631	Polycystic Ovary Syndrome	C0032460	1	477	0.0003909068023787432	0.000782878411911	BCL2
632	Dementia	C0497327	1	477	0.0003909068023787432	0.0007841191067	BCL2
633	Acute myocardial ischemia	C0151744	1	484	0.0004024763749369553	0.000785359801489	BCL2
634	Thyroid Neoplasms	C0040136	1	486	0.00040581289646868246	0.000786600496278	BCL2
635	Major depressive disorder	C1269683	1	489	0.00041084360857035485	0.000787841191067	BCL2
636	Combined Hepatocellular Carcinoma and Cholangiocarcinoma	C0221287	1	497	0.00042441031967632714	0.000789081885856	BCL2
637	Abnormality of abdomen morphology	C4020869	1	505	0.0004381974288739654	0.000790322580645	BCL2
638	Malignant neoplasm of endometrium	C0007103	1	506	0.0004399362986652333	0.000791563275434	BCL2
639	Uterine Corpus Cancer	C0153574	1	506	0.0004399362986652333	0.000792803970223	BCL2
640	Acute leukemia	C0085669	1	525	0.00047362919487936583	0.000794044665012	BCL2
641	Herpes Simplex Infections	C0019348	1	529	0.0004808808557427158	0.000795285359801	BCL2
642	Localized skin lesion	C0850826	1	530	0.0004827023526903229	0.000796526054591	BCL2
643	Myeloid leukemia	C0023470	1	533	0.0004881876118201234	0.00079776674938	BCL2
644	Congenital chromosomal disease	C0008626	1	537	0.0004955493884175599	0.000799007444169	BCL2
645	Malaria	C0024530	1	539	0.0004992509905046294	0.000800248138958	BCL2
646	Depressive Disorder	C0011581	1	543	0.0005066954181601746	0.000801488833747	BCL2
647	Medulloblastoma	C0025149	1	543	0.0005066954181601746	0.000802729528536	BCL2
648	Severe combined immunodeficiency due to ADA deficiency	C0085110	1	545	0.0005104383501698395	0.000803970223325	BCL2
649	Xenograft Model	C1520166	1	551	0.0005217496224346752	0.000805210918114	BCL2
650	Non-Hodgkin lymphoma	C0024305	1	556	0.0005312704313363836	0.000806451612903	BCL2
651	Dermatitis, Atopic	C0011615	1	567	0.0005525191903837934	0.000807692307692	BCL2
652	Pancreatic Ductal Adenocarcinoma	C1335302	1	567	0.0005525191903837934	0.000808933002481	BCL2
653	Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma	C0079744	1	568	0.000554471542568935	0.00081017369727	BCL2
654	Immunodeficiency due to defect in CD3-gamma	C0021051	1	571	0.0005603492989584291	0.00081141439206	BCL2
655	Constitutional symptom	C0009812	1	572	0.0005623154398872732	0.000812655086849	BCL2
656	Scleroderma	C0036421	1	573	0.0005642850217403295	0.000813895781638	BCL2
657	Neoplasm by anatomical site	C4023185	1	576	0.0005702144554056154	0.000815136476427	BCL2
658	Increased inflammatory response	C4022803	1	581	0.0005801656819669487	0.000816377171216	BCL2
659	Abnormal inflammatory response	C4022805	1	581	0.0005801656819669487	0.000817617866005	BCL2
660	Abnormality of the intestine	C0021831	1	584	0.000586177676824895	0.000818858560794	BCL2
661	Esophageal carcinoma	C0152018	1	585	0.0005881885649152707	0.000820099255583	BCL2
662	Liver Diseases	C0023895	1	586	0.0005902029176776402	0.000821339950372	BCL2
663	Sepsis	C0243026	1	602	0.0006229006958434757	0.000822580645161	BCL2
664	Hepatic cancer metastatic	C0345904	1	613	0.0006458917824392341	0.00082382133995	BCL2
665	Secondary malignant neoplasm of lung	C0153676	1	614	0.0006480025498674102	0.000825062034739	BCL2
666	Hematological neoplasm	C0376545	1	615	0.0006501168023678172	0.000826302729529	BCL2
667	Diabetic Nephropathies	C0011881	1	616	0.0006522343985612133	0.000827543424318	BCL2
668	Anemia	C0002871	1	627	0.0006757557295467009	0.000828784119107	BCL2
669	Small cell lung cancer	C0149925	1	638	0.0006996937397607539	0.000830024813896	BCL2
670	Scoliosis	C0036439	1	641	0.0007062945836834311	0.000831265508685	BCL2
671	Osteoporosis	C0029456	1	642	0.0007085017320870302	0.000832506203474	BCL2
672	Neoplasms	C0027651	1	646	0.0007173648983421765	0.000833746898263	BCL2
673	Ischemia	C0022116	1	647	0.0007195892787685843	0.000834987593052	BCL2
674	IgA nephropathy, susceptibility to, 3	C0017661	1	650	0.0007262831151525484	0.000836228287841	BCL2
675	Malignant tumor of esophagus	C0546837	1	650	0.0007262831151525484	0.00083746898263	BCL2
676	Abnormality of lung morphology	C4021760	1	651	0.0007285212121668216	0.000838709677419	BCL2
677	Tuberculosis	C0041296	1	652	0.0007307628721375803	0.000839950372208	BCL2
678	B-cell lymphoma	C0079731	1	652	0.0007307628721375803	0.000841191066998	BCL2
679	Thyroid carcinoma	C0549473	1	659	0.0007465505261871064	0.000842431761787	BCL2
680	Leukemogenesis	C0598766	1	660	0.0007488196409135561	0.000843672456576	BCL2
681	Brain neoplasm	C0006118	1	667	0.0007648000771377506	0.000844913151365	BCL2
682	Nasopharyngeal carcinoma, susceptibility to, 3	C2931822	1	671	0.0007740075750332087	0.000846153846154	BCL2
683	Epilepsy	C0014544	1	673	0.0007786319391051011	0.000847394540943	BCL2
684	Astrocytoma	C0004114	1	674	0.0007809493222994401	0.000848635235732	BCL2
685	EMG: myopathic abnormalities	C0000768	1	675	0.0007832701112877594	0.000849875930521	BCL2
686	Colitis, Ulcerative	C0009319	1	679	0.0007925877522686475	0.00085111662531	BCL2
687	Esophageal Neoplasms	C0014859	1	686	0.0008090261626327866	0.000852357320099	BCL2
688	Cataract, autosomal recessive congenital 5	C0086543	1	690	0.000818495349673154	0.000853598014888	BCL2
